<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="223908">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00167752</url>
  </required_header>
  <id_info>
    <org_study_id>2002-0420</org_study_id>
    <nct_id>NCT00167752</nct_id>
  </id_info>
  <brief_title>Psychiatric Problems in Chronic Skin Diseases</brief_title>
  <official_title>Quality of Life, Emotional and Sleep Problems in Chronic Skin Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the prevalence of depression, anxiety, and sleep
      problems in patients with chronic skin diseases in dermatology clinics at the University of
      Wisconsin Hospital and Clinics.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2002</start_date>
  <primary_completion_date type="Actual">February 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <condition>Psoriasis</condition>
  <condition>Acne</condition>
  <condition>Vitiligo</condition>
  <condition>Atopic Dermatitis</condition>
  <condition>Pruritic Dermatitis</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects suffering from a chronic skin condition that has lasted over six months

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ladan Mostaghimi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 24, 2016</lastchanged_date>
  <firstreceived_date>September 11, 2005</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Psoriasis</mesh_term>
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
    <mesh_term>Vitiligo</mesh_term>
    <mesh_term>Skin Diseases</mesh_term>
    <mesh_term>Pruritus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
